4/14/2021CMJ: Changing Profiles of Cancer Burden Worldwide and in China

4/14/2021Simcere's Marketing Application for First-to-copy Ibrutinib Accepted b...

4/14/2021BioDuro-Sundia Initiates GMP Clinical Batch Manufacturing at New China...

4/14/2021Eli Lilly Licenses Greater China Rights of Alpha-synuclein Targeted Th...

4/14/2021SAMR Fines Yangtze River Pharma CNY 764M for Violations of Anti-Monop...

4/13/2021Abcam and MEDx Extend Precision Medicine Strategic Partnership

4/13/2021Pharma MNCs Step Up Alliances with Local Players in Chinese Market

4/13/2021China Approves New COVID-19 Vaccine for Clinical Trials

4/13/2021CDE Solicits Comments on the Technical Guidelines for Clinical Trial o...

4/13/2021NMPA Revises Package Inserts of Tramadol Hydrochloride Suppository and...

4/13/2021CNIPA Invalidates Pfizer's Chinese Patent of Sutent (Sunitinib)

4/12/2021Review of R&D Spending of Listed Chinese Biopharma Firms 2018-2020

4/12/2021NMPA Accepts NDA for Ocumension's OT-401 (YUTIQ) on Real World Data

4/12/2021Sorrento Therapeutics To Buy ACEA Therapeutics For $38M in Stock

4/12/2021NMPA Outlines Process and Prospects of ICH in China at Latest Symposiu...

4/12/2021CDE Solicits Comments on Proposed Technical Guidelines for BE Study of...

4/12/2021PharmaDJ's China Biotech Fundraising Tracker: Feb 2021

4/12/2021FiercePharma: BeiGene Details Novartis-partnered PD-1's First Global P...

4/9/2021NMPA Issues the List of Reference Formulations for GQCE Studies (40th ...

4/9/2021Recent Executive Moves

4/8/2021Clinigen Launches Managed Access Program with BeiGene for Zanubrutinib

4/8/2021China to Improve BMI Outpatient Coverage As It Reforms Individual Acco...

4/8/2021NHC Issues Notice to Strengthen Management of Microbial Drugs to Conta...

4/8/2021China Introduces New Preferential Policies in Hainan to Boost Sectors ...

4/8/2021Biogen and Bio-Thera Solutions Announce License Deal for Actemra Biosi...

4/8/2021BeiGene's Guangzhou Biologics Plant Granted First Commercial Manufactu...

4/8/2021BeiGene Launches BRUKINSA® (Zanubrutinib) in Canada for Waldenström'...

4/8/2021China's 14th Five-Year Plan (2021-2025): Signposts for Doing Business ...

4/8/2021MNCs Rethink China Strategy as New Opportunities Emerge in Special Zon...

4/7/2021Shanghai Henlius Biotech Maps Out Its Biosimilars Future

Page:135/719 Total number of articles:21549: [First][<<] [133] [134] [135] [136] [137] [>>] [End]